[go: up one dir, main page]

ES2097747T3 - Molecula de adhesion intercelular 2 y sus ligandos de union. - Google Patents

Molecula de adhesion intercelular 2 y sus ligandos de union.

Info

Publication number
ES2097747T3
ES2097747T3 ES90104295T ES90104295T ES2097747T3 ES 2097747 T3 ES2097747 T3 ES 2097747T3 ES 90104295 T ES90104295 T ES 90104295T ES 90104295 T ES90104295 T ES 90104295T ES 2097747 T3 ES2097747 T3 ES 2097747T3
Authority
ES
Spain
Prior art keywords
molecula
linkages
union
intercellular adhesion
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90104295T
Other languages
English (en)
Inventor
Timothy Alan Springer
Michael Loran Dustin
Donald E Staunton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Childrens Hospital
Original Assignee
Immune Disease Institute Inc
Center for Blood Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Disease Institute Inc, Center for Blood Research Inc filed Critical Immune Disease Institute Inc
Application granted granted Critical
Publication of ES2097747T3 publication Critical patent/ES2097747T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LAS MOLECULAS DE ADHESION INTERCELULAR (ICAM-2) ESTAN ENVUELTAS EN EL PROCESO A TRAVES DEL CUAL SE RECONOCEN LOS LINFOCITOS QUE SE SITUAN EN LOS LUGARES DE INGLAMACION Y ATACAN LOS SUSTRATOS CELULARES DURANTE LA INFLAMACION. LA INVENCION VA DIRIGIDA A DICHA MOLECULA, A LOS ENSAYOS DE APANTALLAMIENTO PARA IDENTIFICAR DICHAS MOLECULAS Y A LOS ANTICUERPOS CAPACES DE UNIRLAS. LA INVENCION TAMBIEN INCLUYE EL USO PARA LA ADHESION DE LAS MOLECULAS Y PARA LOS ANTICUERPOS QUE ES CAPZ DE ENLAZAR.
ES90104295T 1989-03-09 1990-03-07 Molecula de adhesion intercelular 2 y sus ligandos de union. Expired - Lifetime ES2097747T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32123889A 1989-03-09 1989-03-09
US45429489A 1989-12-22 1989-12-22

Publications (1)

Publication Number Publication Date
ES2097747T3 true ES2097747T3 (es) 1997-04-16

Family

ID=26982877

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90104295T Expired - Lifetime ES2097747T3 (es) 1989-03-09 1990-03-07 Molecula de adhesion intercelular 2 y sus ligandos de union.

Country Status (16)

Country Link
EP (1) EP0387668B1 (es)
JP (1) JP3369166B2 (es)
KR (1) KR0169728B1 (es)
AT (1) ATE146222T1 (es)
AU (1) AU647017B2 (es)
CA (1) CA2011633C (es)
DE (1) DE69029336T2 (es)
DK (1) DK0387668T3 (es)
ES (1) ES2097747T3 (es)
FI (1) FI100994B (es)
GR (1) GR3022670T3 (es)
HU (1) HU214247B (es)
IL (1) IL93680A (es)
MX (1) MX9203469A (es)
NO (1) NO178862C (es)
NZ (2) NZ245651A (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
HU217792B (hu) * 1989-03-16 2000-04-28 Dana Farber Cancer Institute Eljárás intercelluláris adhéziós molekula (ICAM-1) oldható származékai és ezeket tartalmazó gyógyszerkészítmények előállítására
EP0468257B1 (en) * 1990-07-20 1999-09-01 Bayer Corporation Multimeric form of human rhinovirus receptor protein
US5871733A (en) * 1990-07-20 1999-02-16 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US5686581A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric form of human rhinovirus receptor protein
EP0510483A1 (en) * 1991-04-22 1992-10-28 Boehringer Ingelheim Pharmaceuticals Inc. Method for the detection of viruses
US5460945A (en) * 1991-05-30 1995-10-24 Center For Blood Research, Inc. Device and method for analysis of blood components and identifying inhibitors and promoters of the inflammatory response
IL102176A (en) * 1991-06-11 2001-09-13 Blood Res Center Recombinant nucleic acid molecule capable of encoding intercellular adhesion molecule 3, functional derivatives of icam-3 and pharmaceutical compositions containing icam-3 or functional derivatives thereof
US5629162A (en) * 1991-06-11 1997-05-13 The Center For Blood Research Method of identifying agents which modulate ICAM-3 binding to LFA-1
US5861151A (en) * 1991-12-20 1999-01-19 Bristol-Myers Squibb Co Soluble fusion molecules with binding specificity for cell adhesion molecules
US6818743B1 (en) 1992-01-27 2004-11-16 Icos Corporation I-CAM related protein
EP0578819A4 (en) * 1992-01-27 1994-10-12 Icos Corp Icam-related protein.
US6100383A (en) * 1992-01-27 2000-08-08 Icos Corporation Fusion proteins comprising ICAM-R polypeptides and immunoglobulin constant regions
US5989843A (en) * 1992-01-27 1999-11-23 Icos Corporation Methods for identifying modulators of protein kinase C phosphorylation of ICAM-related protein
US6153395A (en) * 1992-01-27 2000-11-28 Icos Corporation ICAM-related protein
US5880268A (en) * 1992-01-27 1999-03-09 Icos Corporation Modulators of the interaction between ICAM-R and αd /CD18
US5532127A (en) * 1992-01-27 1996-07-02 Icos Corporation Assay for 1-CAM related protein expression
US5837822A (en) * 1992-01-27 1998-11-17 Icos Corporation Humanized antibodies specific for ICAM related protein
US5525487A (en) * 1992-01-27 1996-06-11 Icos Corporation DNA encoding I-CAM related protein
DE69326829D1 (de) * 1992-02-28 1999-11-25 Univ Texas Verwendung einer therapeutischen ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON VERBRENNUNGEN
ATE161192T1 (de) * 1992-08-21 1998-01-15 Genentech Inc Verfahren zur behandlung einer durch lfa-1 vermittelten störung
WO1994011400A1 (en) * 1992-11-18 1994-05-26 Helsinki University Licensing Ltd. Oy Peptides from human icam-2 and from human icam-1 and their analogs for use in therapy and diagnosis
WO1997011168A1 (en) * 1995-09-22 1997-03-27 Relag Pty. Limited Promoter and uses thereof
US5914112A (en) * 1996-01-23 1999-06-22 Genentech, Inc. Anti-CD18 antibodies in stroke
US20020081294A1 (en) 1996-01-23 2002-06-27 Genentech, Inc. Co-administration of a thrombolytic and an anti-CD18 antibody in stroke
DK1163003T3 (da) 1999-03-19 2009-11-30 Genentech Inc Behandling af LFA-1 associerede lidelser med ögende doser af LFA-1-antagonist
US6582698B1 (en) 1999-03-19 2003-06-24 Genentech, Inc. Treatment method
BRPI0511305A (pt) 2004-06-09 2007-12-04 Genentech Inc método de aliviar um granuloma anular ou sarcóide, artigo manufaturado e uso de um antagonista de lfa-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU629189B2 (en) * 1987-05-04 1992-10-01 Dana-Farber Cancer Institute Intercellular adhesion molecules and their binding ligands
ATE128727T1 (de) * 1987-05-04 1995-10-15 Dana Farber Cancer Inst Inc Interzellulare adhäsions-moleküle und deren bindungsliganden.
WO1989008114A1 (en) * 1988-02-25 1989-09-08 The General Hospital Corporation Rapid immunoselection cloning method
EP0391088B1 (en) * 1989-03-16 1997-01-02 Center For Blood Research, Inc. Use of functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy

Also Published As

Publication number Publication date
AU5117290A (en) 1990-09-13
FI901170A0 (fi) 1990-03-08
CA2011633A1 (en) 1990-09-09
DE69029336T2 (de) 1997-07-03
HU901367D0 (en) 1990-05-28
DE69029336D1 (de) 1997-01-23
NO178862B (no) 1996-03-11
EP0387668A1 (en) 1990-09-19
IL93680A (en) 1996-01-31
NZ232833A (en) 1993-05-26
KR900013978A (ko) 1990-10-22
NO901093L (no) 1990-09-10
JPH0361486A (ja) 1991-03-18
AU647017B2 (en) 1994-03-17
ATE146222T1 (de) 1996-12-15
HU214247B (hu) 1998-03-02
GR3022670T3 (en) 1997-05-31
KR0169728B1 (ko) 1999-01-15
JP3369166B2 (ja) 2003-01-20
NO178862C (no) 1996-06-19
DK0387668T3 (da) 1997-03-03
EP0387668B1 (en) 1996-12-11
CA2011633C (en) 2007-05-15
NZ245651A (en) 1997-06-24
IL93680A0 (en) 1990-12-23
MX9203469A (es) 1992-07-01
NO901093D0 (no) 1990-03-08
FI100994B (fi) 1998-03-31

Similar Documents

Publication Publication Date Title
ES2097747T3 (es) Molecula de adhesion intercelular 2 y sus ligandos de union.
FI882037A (fi) Intercellulaera adhesionmolekyler och deras bindande ligander.
EA199700219A1 (ru) Мультиматричное мультиспецифическое электрохемилюминесцентное испытание
ES2171558T3 (es) Servicios accionados por voz.
ES2110230T3 (es) Ensayo de rapamicina.
BG46598A3 (bg) Метод за получаване на алфа-хетероциклично заместени толунитрили
DE69017353D1 (de) Beleuchtungskörper für äusserlich beleuchtete Anzeige.
ES2151603T3 (es) Anticuerpo monoclonal contra cd44v6.
ES2101499T3 (es) Fibras.
ES2141559T3 (es) Derivados de 2-ciano-1-sulfonamidofenil-1,3-diona y su uso como herbicidas.
DK412589A (da) Alfa-underenheden af lfa-1-leukocytadhaesionsreceptoren
ES2016228T3 (es) Membrana deformable para tunel de intercirculacion entre vehiculos sucesivos ferroviarios o de carretera.
PT91834A (pt) Processo para a preparacao de moleculas de adesao intercelular e de ligantes que promovem a ligacao destas moleculas bem como de agentes terapeuticos e de diagnostico que os contem
ES2163418T3 (es) Inhibidores de una proteasa que es capaz de separar el receptor tnf soluble p55 del receptor tnf unido a la celula.
AR022236A1 (es) Citoquinas mamiferas purificadas; reactivos y metodos relacionados
SE8403630L (sv) Humana proteiner
ATE18920T1 (de) Radioimmunoassay fuer fibrinopeptid a.
IT1246191B (it) Indicatore dell'intensita' di campo nell'ispezione magnetoscopica.
ATE122566T1 (de) Für kappa-opioid-rezeptoren spezifische dynorphinanaloga.
ES2035299T3 (es) Un equipo reactivo para su utilizacion en la determinacion de un analito.
FR2756827B1 (fr) Composes synthetiques biepitopiques utilisables comme etalons dans les dosages biologiques de la troponine i
EA199700223A1 (ru) Бициклические антагонисты тахикининов, их получение и применение в фармацевтической композиции
AR004719A1 (es) Compuestos debisindolilmaleimidas con un punte n, n' y formulaciones farmaceuticas que los contienen, dichos compuestos son utiles comointermediarios para preparar otras bisindolilmaleimidas que poseen dicho puente n, n'
ES2159763T3 (es) (eter)sulfatos de alcoholes grasos con comportamiento mejorado en frio.
ES2068863T3 (es) Deteccion inmunologica de atracina y de derivados de atracina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 387668

Country of ref document: ES